Caricamento...
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
BACKGROUND. Phase III trials show sorafenib improves survival in advanced hepatocellular carcinoma (HCC). Because of narrow trial eligibility, results may not be generalizable to a broader HCC population. We sought to evaluate the effectiveness of initial sorafenib versus no treatment among Medicare...
Salvato in:
| Pubblicato in: | Oncologist |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AlphaMed Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016063/ https://ncbi.nlm.nih.gov/pubmed/27185615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0478 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|